Structured evidence table for Methylfolate Pregnancy Guideline, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Methylfolate Pregnancy Guideline | Epidemiological evidence highlights both the high prevalence and serious consequences of these disorders. | 3 | Zhang Tingyin (2026) | Multigene Screening of B-Vitamin Metabolism Pathways in Hypertensive Disorders of Pregnancy: Toward Precision Prenatal Care |
| Methylfolate Pregnancy Guideline | For instance, a large national cohort study in China involving more than two million pregnant women reported that ambient environmental factors, such as temperature fluctuations, can influence the incidence of preeclampsia and gestational hypertension, underscoring the multifactorial nature of HDP.The global burden of HDP is also reflected in its associated maternal and perinatal morbidity and mortality. | 3 | Zhang Tingyin (2026) | Multigene Screening of B-Vitamin Metabolism Pathways in Hypertensive Disorders of Pregnancy: Toward Precision Prenatal Care |
| Methylfolate Pregnancy Guideline | Affected women have increased risks of cardiovascular and cerebrovascular diseases, cognitive decline, and other neurological disorders later in life.Collectively, these findings highlight the critical need for early diagnosis, careful risk stratification, and effective management strategies to reduce both immediate and long-term adverse outcomes associated with HDP. | 3 | Zhang Tingyin (2026) | Multigene Screening of B-Vitamin Metabolism Pathways in Hypertensive Disorders of Pregnancy: Toward Precision Prenatal Care |
| Methylfolate Pregnancy Guideline | 1 2 3 4 5–7 HDP remain a major clinical challenge worldwide, posing substantial risks to both maternal and fetal well-being. | 3 | Zhang Tingyin (2026) | Multigene Screening of B-Vitamin Metabolism Pathways in Hypertensive Disorders of Pregnancy: Toward Precision Prenatal Care |
| Methylfolate Pregnancy Guideline | In addition, SSRI/SNRIs have side effects, such as dietary disorders, reduced sexual function, headaches, insomnia, dizziness, sweating, tremors and anxiety. | 3 | Tobin Derek (2024) | Targeting Divergent Pathways in the Nutritional Management of Depression |
| Methylfolate Pregnancy Guideline | Effective treatments may therefore require a multi-component approach in order to target these diverse mechanisms that result in depression []. | 3 | Tobin Derek (2024) | Targeting Divergent Pathways in the Nutritional Management of Depression |
| Methylfolate Pregnancy Guideline | While the efficacy of many nutrient supplements for treating MDD is questionable, several have garnered considerable support from convergent sources of evidence, from preclinical (mechanistic) research to randomised controlled trials. | 3 | Tobin Derek (2024) | Targeting Divergent Pathways in the Nutritional Management of Depression |
| Methylfolate Pregnancy Guideline | 1 2 2 Major Depressive Disorder (MDD) is a debilitating condition which constitutes one of the most prevalent mental health diagnoses globally. | 3 | Tobin Derek (2024) | Targeting Divergent Pathways in the Nutritional Management of Depression |
Source documents